GMED insider trading — Globus Medical Inc
Over the last 90 days, insiders at Globus Medical Inc (GMED) made 0 open-market purchases worth $0 and 2 open-market sales worth $4.41M, making them net sellers by $4.41M. The largest sale was by Tobin James R (Director), who sold 30,000 shares for $2.24M on Sep 15, 2026.
Updated Oct 16, 2026.
Recent GMED insider transactions
Every Form 4 filed by Globus Medical Inc officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Tobin James R | Director | M · Option exercise | Direct | 30,000 | $58.72 | $1.76M | Form 4 |
| Sep 15, 2026 | Tobin James R | Director | S · Sale | Direct | 30,000 | $74.58 | $2.24M | Form 4 |
| Aug 18, 2026 | Zarrilli Stephen T | Director | M · Option exercise | Direct | 25,000 | $53.27 | $1.33M | Form 4 |
| Aug 18, 2026 | Zarrilli Stephen T | Director | S · Sale | Direct | 25,000 | $87.04 | $2.18M | Form 4 |
| Jul 27, 2026 | Davidar David D | Director | G · Gift | Direct | 2,500 | — | — | Form 4 |
GMED insider trading FAQ
Are insiders buying GMED stock?
Not on the open market. In the last 90 days, Globus Medical Inc insiders made no open-market purchases, and 2 open-market sales totaling $4.41M. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading GMED?
Recent sellers: Tobin James R, Zarrilli Stephen T.
Where does GMED insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.